Has Katharine Nataro received payments from drug or device companies?

Yes. Drug and device makers reported $4,297 in general payments to Katharine Nataro across 255 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Katharine Nataro did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Katharine Nataro come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Katharine Nataro

Psychiatric/Mental Health · Fairlawn, OHNPI 1851813695

Payments from drug & device makers

$4,297in general payments, 2019–2025

Across 255 payments — averaging $16.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$638
Alkermes, Inc.$563
AbbVie$512
Johnson & Johnson$492
Neurocrine Biosciences, Inc.$452
Teva Pharmaceuticals USA, Inc.$450
plus $1K from 9 others

What the payments were for

Food & beverage$4,26999%
Education$281%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	30	$638
Alkermes, Inc.	29	$563
AbbVie	55	$512
Johnson & Johnson	33	$492
Neurocrine Biosciences, Inc.	16	$452
Teva Pharmaceuticals USA, Inc.	35	$450
Otsuka America Pharmaceutical, Inc.	19	$368
Axsome Therapeutics, Inc.	10	$248
E.r. Squibb & Sons, L.L.C.	8	$220
Lundbeck LLC	6	$105
Supernus Pharmaceuticals, Inc.	5	$94
Tris Pharma Inc	5	$86
Takeda Pharmaceuticals U.S.A., Inc.	1	$28
Vanda Pharmaceuticals Inc.	2	$27
Almatica Pharma LLC	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,297 in reported general payments places this provider in the 85th percentile of 1,808 psychiatric/mental health providers in Ohio.

See all psychiatric/mental health providers in Ohio →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
CaplytaLumateperone Tosylate	16	$28,885
VraylarCariprazine Hcl	19	$25,622
TrintellixVortioxetine Hydrobromide	32	$16,261
BelsomraSuvorexant	34	$15,293
Vilazodone Hcl	23	$2,200
Quetiapine Fumarate ErQuetiapine Fumarate	15	$2,147
Hydroxyzine Hcl	95	$1,776
Clonidine	22	$1,713
Buspirone Hcl	119	$1,608
Duloxetine Hcl	73	$1,503
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine	16	$1,171
Trazodone Hcl	88	$839
Aripiprazole	48	$675
Desvenlafaxine Succinate ErDesvenlafaxine Succinate	13	$663
Sertraline Hcl	85	$576

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta	$638	$28,88516 claims
AbbVieVraylar	$512	$25,62219 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix	$28	$16,26132 claims
Almatica Pharma LLCSertraline Hcl	$14	$57685 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,808 psychiatric/mental health providers in Ohio.

Other psychiatric/mental health in Fairlawn

Mark GarretsonFairlawn$14K
Dewan Smith-WilliamsFairlawn$14K
Crystal TravisJackson$333K
Kristina RoweIronton$253K
Patricia SparksPortsmouth$210K
Mary HallWarren$195K
Kassandra KornbauCanfield$170K
Terri PopovitzCincinnati$161K
Steven MatesDayton$121K
Robert ParsonsYoungstown$119K

See the full list for Ohio →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →